Anti-erythropoietin antibody– mediated pure red cell aplasia in a patient with chronic kidney disease
New Zealand Medical Journal · 12.06.2026 · 139 (1636) · 114-116
DOI: 10.26635/6965.7139 ↗Kurz gefasst
Fallbericht in der Zeitschrift New Zealand Medical Journal, online erschienen am 12.06.2026. Verfasst von Devon Lowyim und 1 weiteren Autor:innen. Beteiligte Einrichtung: House Officer, Department of Medicine, North Shore Hospital, Auckland, New Zealand.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- House Officer, Department of Medicine, North Shore Hospital, Auckland, New Zealand.
- Registrar, Department of Medicine, Waitakere Hospital, Auckland, New Zealand.
Zitieren
APA
Lowyim, D., & Stevenson, M. (2026). Anti-erythropoietin antibody– mediated pure red cell aplasia in a patient with chronic kidney disease. New Zealand Medical Journal, 139(1636), 114-116. https://doi.org/10.26635/6965.7139
Vancouver
Lowyim D, Stevenson M. Anti-erythropoietin antibody– mediated pure red cell aplasia in a patient with chronic kidney disease. New Zealand Medical Journal. 2026;139(1636):114-116. doi:10.26635/6965.7139
BibTeX
@article{Lowyim2026,
author = {Lowyim, Devon and Stevenson, Matthew},
title = {Anti-erythropoietin antibody– mediated pure red cell aplasia in a patient with chronic kidney disease},
journal = {New Zealand Medical Journal},
year = {2026},
volume = {139},
number = {1636},
pages = {114--116},
doi = {10.26635/6965.7139}
}
EUVIMED